Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 1 4Phase 2 3Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2CNS 1

Conditions

Neuroblastoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Population Groups × Clear all
NCT00072358 2022-05-16

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
291 enrolled 7 charts
CNS

Neuroblastoma

NCT01048762 2015-10-22

Multidisciplinary Rehabilitation After Cancer Pulmonis Operation

Aalborg University Hospital

Phase 2 Completed
78 enrolled
Thoracic

Lung Neoplasms

NCT01749072 2012-12-13

Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients

Peking Union Medical College Hospital

Phase 2 Unknown
120 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡